ShowQuick ReadSummary is AI-generated, newsroom-reviewed
- US drug regulator, the FDA, confirmed that cough syrups linked to deaths in India were not shipped to the US
- It said it was aware of news reports of contamination in children's cough and cold medicine in India
- ColdRif brand cough syrup was banned after tests found toxic chemical on October 2
Did our AI summary help? Let us know. Switch To Beeps Mode The US Food and Drug Administration confirmed on Friday that toxic cough syrups linked to children's deaths in India had not been shipped to the United States.
The World Health Organization has said India has a "regulatory gap" in screening locally sold syrup medicines.
The US FDA said it was aware of news reports of devastating, ongoing diethylene glycol and ethylene glycol contamination in children's cough and cold medicine in India.
Indian authorities advised the public to avoid two more brands of cough syrup on Wednesday following the deaths of 17 children under age five, linked to a toxic ingredient.
The children died in India over the past month after consuming cough medicine containing toxic diethylene glycol in quantities nearly 500 times the permissible limit, officials said. The deaths were all linked to the Coldrif medicine brand, which was banned after a test confirmed the presence of the chemical on October 2.
India's health authority, the Central Drugs Standard Control Organization, informed the US regulator that these products were not exported from India to any other country, the FDA said.
The FDA also said it remains vigilant to prevent contaminated drugs from entering the US and asked manufacturers to ensure that drugs marketed in the US are safe and of the highest quality.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Disclaimer: If your rights are infringed, please contact the webmaster and we will delete the infringing content in a timely manner. Thank you for your cooperation! |
